No Data
Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client
Wall Street Today: Nvidia and Chips Pull Back Hard, Market Falls, Dow Holds On
The Zacks Analyst Blog Highlights Cisco Systems, Abbott Laboratories and Coca-Cola
This Is What Whales Are Betting On Abbott Laboratories
Abbott Laboratories: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund
Redburn Atlantic Adjusts Abbott Laboratories Price Target to $130 From $120